Search

You searched for "registrar"

1271 results found

Technique of deep corneal foreign body removal

3 February 2026 | | EYE - Glaucoma, EYE - Cornea
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. The objective is to demonstrate a method for the safe and successful...

Eye

Midland Eye performs its first Presserflo Microshunt to treat Glaucoma

25 September 2023 | Midland Eye, Glaucoma, Presserflo Microshunt, Surgery, Success stories
Eye clinic, Midland Eye, announces the success of its first sight-saving Preserflo Microshunt glaucoma procedure.

High dose (2.5mg) bevacizumab for postradiation cystoid macular oedema

1 April 2017 | | EYE - Pathology, EYE - Oncology | Anti-VEGF, Cystoid macular edema, Melanoma, Radiation damage, Radiotherapy, Tumor
The authors present a retrospective, interventional case series investigating the efficacy of high dose (2.5mg/0.1ml) intravitreal bevacizumab in the treatment of persistent postradiation (Iodine-125 plaque brachytherapy for uveal melanoma) cystoid macular oedema (CME). Persistent CME was defined as increased or...

Bandage contact lens cultures after corneal collagen cross-linking

1 August 2016 | | EYE - Cornea, EYE - General | Bacterial contamination, contact lens, corneal collagen cross-linking, keratoconus, photorefractive keratotomy
Corneal collagen cross-linking (CCL) is a treatment modality that has been shown to stop the progression of keratoconus. There have also been reports that CCL acts as an antimicrobiologic agent in treating resistant microbial keratitis. This study aimed to investigate...

Subthreshold micropulse laser treatment in chronic central serous chorioretinopathy

1 February 2016 | | EYE - Vitreo-Retinal
This retrospective study was conducted to assess the treatment of 38 patients of chronic central serous chorioretinopathy with a 577-nm subthreshold micropulse laser (SML) Supra Scan Quantel Medical. Eighteen patients of these had persistent subretinal fluid (SRF) after photodynamic therapy....

Immunoglobulin G4-related ophthalmic disease – what is it? (Part 2)

3 April 2023 |
Part 2: Clinical presentation and treatment (see part 1 here) Introduction IgG4-related disease (IgG4-RD) is understood to have a vast clinicopathological spectrum; nearly every organ has had reported involvement. Similarly, IgG4-related ophthalmic disease (IgG4-ROD) is known to affect nearly every...

How to nearly (but not quite) get into ST1 ophthalmology training – some reflections

1 February 2022 | | EYE - General
Ophthalmology is often considered to be an elite, highly competitive specialty, with little room for failure. Candidates and trainees tend to cultivate a certain urbane and confident style, and the bottleneck at ST1 can feel rather intense. The majority of...

Interview with Clinical Director of OpenEyes

1 April 2015 | | EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Professor James Morgan is an Ophthalmic Consultant at Cardiff Hospital and also the clinical director of the OpenEyes programme. Given the national push for electronic records we felt hearing directly from James would be of interest. The interview was conducted...

Transferring imaging from primary to secondary care (part 2)

5 October 2020 | | EYE - General
Transferring clinical imaging from high street optometrists to secondary care is an increasingly requested option, especially in the context of the COVID-19 pandemic. A wide variety of solutions exist to allow this, each with their own merits and shortcomings. In...

World Diabetes Day workshop highlights the importance of education to protect the sight of people living with diabetes

24 November 2022
Health professionals from all over the world came together to mark World Diabetes Day on 14 November 2022 through an online workshop celebrating progress in development of diabetic retinopathy (DR) services in low-and middle-income countries (LMICs).

British Council for Prevention of Blindness has a new Chairman

9 November 2020
BCPB’s new Chairman Mr Michael Burdon FRCOphth FRCP is a consultant ophthalmologist at Queen Elizabeth Hospital Birmingham with a specialist interest in neuro-ophthalmology.